BridgeBio has secured FDA Priority Review for its oral infigratinib [...]
Compass Pathways has reported positive six-month results from its second [...]
Merck has announced that the US Food and Drug Administration [...]
BridgeBio has secured FDA Priority Review for its oral infigratinib [...]
Compass Pathways has reported positive six-month results from its second [...]
Merck has announced that the US Food and Drug Administration [...]